Tuesday

25th Apr 2017

Drug supplies to EU crisis countries at risk, warn health analysts

  • Drug speculation threatens supplies, says GlobalData (Photo: Derek K. Miller)

Speculators are threatening the supply of medication to countries worst hit by the sovereign debt crisis, according to research by business analysts GlobalData.

GlobalData's report, published Wednesday (22 August) claimed that pharmacies in Greece and other South Mediterranean countries had cut drug prices in a bid to enable people to pay for their medicines.

Dear EUobserver reader

Subscribe now for unrestricted access to EUobserver.

Sign up for 30 days' free trial, no obligation. Full subscription only 15 € / month or 150 € / year.

  1. Unlimited access on desktop and mobile
  2. All premium articles, analysis, commentary and investigations
  3. EUobserver archives

EUobserver is the only independent news media covering EU affairs in Brussels and all 28 member states.

♡ We value your support.

If you already have an account click here to login.

But theprice-cuts had led to speculators and wholesalers buying up medicines at knock-down prices in one member state and selling them in another.

GlobalData analyst Michael Leibfried, who asserted that drug companies in Europe were facing "renewed pricing pressure from all directions", described the practice as a "lucrative export carry trade" that was "shrinking prices in other countries due to reference pricing." The practice also threatens the supply of medicines to the EU's crisis-hit countries.

Although OECD figures suggest that European governments are still allocating 8-12% of public spending to healthcare, austerity budgets have already seen attempts by governments to cut back on drug bills, even in more prosperous countries.

Following the lead of the UK's National Institute for Clinical Excellence (Nice), which controls drug purchases for the NHS, the German government last year adopted legislation requiring drug companies to prove the price benefits of new medicines, in a move aimed at tightening costs for new medicines.

Under EU law national governments are solely responsible for negotiating drug prices with companies. However, GSK boss Andrew Witty, who also leads the European Federation of Pharmaceutical Industries and Associations (EFPIA), wants EU countries to agree to exclude bail-out countries from price referencing.

Last month the lobby group asked the EU commission to impose a temporary ban on drug re-exports, although this would breach internal market rules on the free movement of goods and services.

The EFPIA insists that drug companies made discounts and price-cuts worth €7 billion in 2010 and 2011 in the five countries Greece, Ireland, Italy, Portugal and Spain, accounting for 8 percent of the industry's turnover. They were also risking further multi-billion euro losses by making emergency plans to supply drugs to Greece, and other countries, in the event of them being forced out of the eurozone, Witty said.

Pharmaceutical giants are concerned that lower drug prices in crisis-hit countries are being used for benchmark pricing of drugs. Most member states base their medicine purchase prices on average prices across the EU.

Critics claim that the reference pricing scheme prevents companies charging over the odds for new drugs.

Meanwhile, drug giants also have fears about whether governments can pay their bills. In July, Swiss company Roche claimed that the five crisis euro countries owed €1.2 billion to settle unpaid drug bills. Figures collected by pharmaceuticals indicated that only 1 percent of drug sales to the Greek government had been paid for in the first three months of 2012.

IMF worried by social cost of Greek austerity

The Greek economy and its people are reaching the "limit" of what they can endure in terms of austerity cuts, a senior IMF official has said in unusually political remarks.

EU drugs regulator accused of being too cozy with Big Pharma

The European Parliament has refused to sign off on the accounts of the EU agency responsible for making sure all medicines in Europe are safe and effective for its citizens to use, accusing the body of being too close to Big Pharma.

Feature

How a Swedish love mob fights online hate

A Swedish group helping people to take the fight against online hate and lies had busy days after the recent terrorist attack in Stockholm.

MEPs set out to give posted workers equal pay

A revision of the posted workers directive aims to make the single market fairer, but critics see efforts to root out "social dumping" as disguised protectionism.

Feature

Civil society steps in to fight rising obesity

By 2030, it is estimated that more than 50 percent of Europeans will be obese. With a lack of public policies and coherent strategies, civil society is often the one trying to find a solution.

Stakeholders' Highlights

  1. Nordic Council of MinistersDeveloping Independent Russian-Language Media in the Baltic Countries
  2. Swedish EnterprisesReform of the European Electricity Market: Lessons from the Nordics, Brussels 2 May
  3. Malta EU 2017Green Light Given for New EU Regulation to Bolster External Border Checks
  4. Counter BalanceCall for EU Commission to Withdraw Support of Trans-Adriatic Pipeline
  5. ACCAEconomic Confidence at Highest Since 2015
  6. European Federation of Allergy and Airways60%-90% of Your Life Is Spent Indoors. How Does Poor Indoor Air Quality Affect You?
  7. European Gaming and Betting AssociationCJEU Confirms Obligation for a Transparent Licensing Process
  8. Nordic Council of MinistersNordic Region and the US: A Time of Warlike Rhetoric and Militarisation?
  9. European Free AllianceEFA MEPs Vote in Favor of European Parliament's Brexit Mandate
  10. Mission of China to the EUXinhua Insight: China to Open up Like Never Before
  11. World VisionViolence Becomes New Normal for Syrian Children
  12. International Partnership for Human RightsTime to Turn the Tide and End Repression of Central Asia's Civil Society

Latest News

  1. Report: Germany blocks post-Dieselgate reform
  2. Russia suspected of Macron hack
  3. EU to exclude financial services from post-Brexit deal
  4. Le Pen-Poutine: des liens qui remontent à loin
  5. Juncker breaks tradition with support for Macron
  6. Les fake news inondent les réseaux sociaux français
  7. Les amis de Le Pen à la Trump Tower
  8. France's election run-off will be far-right versus EU